HEALTH PROFESSIONAL · SOURCE READING

Other therapies as designated for patients with advanced-stage disease

Source: Indolent B-Cell Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: May 14, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment of Indolent Stage I and Indolent, Contiguous Stage II B-Cell Non-Hodgkin Lymphoma / Treatment Options for Indolent Stage I and Indolent, Contiguous Stage II B-Cell NHL

Patients with disease unable to be encompassed by radiation therapy are treated as outlined for patients with stage III or stage IV low-grade lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice